Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kwangmin Choi

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Nature Communications|October 25, 2024
Chemotherapy resistance in acute myeloid leukemia is mediated by A20 suppression of spontaneous necroptosisAshley E Culver-Cochran, Aishlin Hassan, Kathleen Hueneman, et al.
Nature Immunology|April 22, 2020
Adaptive response to inflammation contributes to sustained myelopoiesis and confers a competitive advantage in myelodysplastic syndrome HSCsTomoya Muto, Callum S Walker, Kwangmin Choi, et al.
Cancer Research|August 25, 2012
In vivo regulation of TGF-β by R-Ras2 revealed through loss of the RasGAP protein NF1Deanna M Patmore, Sara Welch, Patricia C Fulkerson, et al.
Oncotarget|November 16, 2017
Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapyKellie B Haworth, Michael A Arnold, Christopher R Pierson, et al.
Cell Reports|February 27, 2020
TIFAB Regulates USP15-Mediated p53 Signaling during Stressed and Malignant HematopoiesisMadeline Niederkorn, Kathleen Hueneman, Kwangmin Choi, et al.
Obesity (Silver Spring, Md.)|September 11, 2025
Exploring Organ-Specific Extracellular Vesicles in Metabolic Improvements Following Bariatric Surgery in Youth With ObesityAhlee Kim, Tsuyoshi Okura, Kwangmin Choi, et al.
American Journal of Cancer Research|April 9, 2020
Polo-like kinase 1 as a therapeutic target for malignant peripheral nerve sheath tumors (MPNST) and schwannomasJianman Guo, Katherine E Chaney, Kwangmin Choi, et al.
Iscience|May 24, 2024
Dysregulated innate immune signaling cooperates with RUNX1 mutations to transform an MDS-like disease to AMLLaura Barreyro, Avery M Sampson, Kathleen Hueneman, et al.
Neoplasia (New York, N.Y.)|December 16, 2014
The transcriptional repressor ZBTB4 regulates EZH2 through a MicroRNA-ZBTB4-specificity protein signaling axisWon Seok Yang, Gayathri Chadalapaka, Sung-Gook Cho, et al.
Life Science Alliance|September 24, 2025
Daytime SHP2 inhibitor dosing, when immune cell numbers are elevated, shrinks neurofibromasNiousha Ahmari, Kwangmin Choi, Jianqiang Wu, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Nature Communications|October 25, 2024
Chemotherapy resistance in acute myeloid leukemia is mediated by A20 suppression of spontaneous necroptosisAshley E Culver-Cochran, Aishlin Hassan, Kathleen Hueneman, et al.
Nature Immunology|April 22, 2020
Adaptive response to inflammation contributes to sustained myelopoiesis and confers a competitive advantage in myelodysplastic syndrome HSCsTomoya Muto, Callum S Walker, Kwangmin Choi, et al.
Cancer Research|August 25, 2012
In vivo regulation of TGF-β by R-Ras2 revealed through loss of the RasGAP protein NF1Deanna M Patmore, Sara Welch, Patricia C Fulkerson, et al.
Oncotarget|November 16, 2017
Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapyKellie B Haworth, Michael A Arnold, Christopher R Pierson, et al.
Cell Reports|February 27, 2020
TIFAB Regulates USP15-Mediated p53 Signaling during Stressed and Malignant HematopoiesisMadeline Niederkorn, Kathleen Hueneman, Kwangmin Choi, et al.
Obesity (Silver Spring, Md.)|September 11, 2025
Exploring Organ-Specific Extracellular Vesicles in Metabolic Improvements Following Bariatric Surgery in Youth With ObesityAhlee Kim, Tsuyoshi Okura, Kwangmin Choi, et al.
American Journal of Cancer Research|April 9, 2020
Polo-like kinase 1 as a therapeutic target for malignant peripheral nerve sheath tumors (MPNST) and schwannomasJianman Guo, Katherine E Chaney, Kwangmin Choi, et al.
Iscience|May 24, 2024
Dysregulated innate immune signaling cooperates with RUNX1 mutations to transform an MDS-like disease to AMLLaura Barreyro, Avery M Sampson, Kathleen Hueneman, et al.
Neoplasia (New York, N.Y.)|December 16, 2014
The transcriptional repressor ZBTB4 regulates EZH2 through a MicroRNA-ZBTB4-specificity protein signaling axisWon Seok Yang, Gayathri Chadalapaka, Sung-Gook Cho, et al.
Life Science Alliance|September 24, 2025
Daytime SHP2 inhibitor dosing, when immune cell numbers are elevated, shrinks neurofibromasNiousha Ahmari, Kwangmin Choi, Jianqiang Wu, et al.
Pageof 8